Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial

Author:

Diamantidis Clarissa J.,Bosworth Hayden B.,Oakes Megan M.,Davenport Clemontina A.,Pendergast Jane F.,Patel Sejal,Moaddeb Jivan,Barnhart Huiman X.,Merrill Peter D.,Baloch Khaula,Crowley Matthew J.,Patel Uptal D.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

CJD

MJC

VA Health Services Research & Development

Senior Career Scientist Award

NIDDK

UDP

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference62 articles.

1. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2016 Accessed 2017, at www.usrds.org/adr.

2. Temporal trends in the prevalence of diabetic kidney disease in the United States;de Boer;JAMA,2011

3. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014;Afkarian;JAMA,2016

4. Diabetic kidney disease: challenges, progress, and possibilities;Alicic;Clin. J. Am. Soc. Nephrol.,2017

5. Prevalence of and trends in diabetes among adults in the United States, 1988-2012;Menke;JAMA,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3